Alex Spyropoulos, MD, FACP, FCCP, FRCPC

Dr. Spyropoulos is a Professor of Medicine at the Zucker School of Medicine at Hofstra/Northwell, Professor at the Center for Health Innovations and Outcomes Research at the Feinstein Institute for Medical Research, and System Director of Anticoagulation Services and Clinical Thrombosis for the Northwell Health System in New York. He is an internationally recognized thought leader in the field of clinical thrombosis and anticoagulant therapy and has been instrumental in the development of hospital-based and outpatient-based protocols for the use of anticoagulants, clinical use of the direct oral anticoagulants, and the management of anticoagulant therapy in perioperative settings and special populations. Dr. Spyropoulos is also the Chief Clinical Advisor for Point of Care Decision Support.

Recent Posts

5 Part Series: Improving the Quality of Chronic Oral Anticoagulation with Evidence-Based Guidelines (Clone)

Part 1: Adverse Drug Events Related to Anticoagulation/VKA 

Coumadin (warfarin) is a tough sell.  As someone who has...

Continue Reading

Use of Outcome Measurements: Warfarin, NOACs and How They Apply to MU and National Quality Measures (Clone)

Part 2 in a 5 part series - Improving the Quality of Chronic Oral Anticoagulation with Evidence-Based Guidelines

 

...

Continue Reading

Clinical Decision Support Tools in the Dosing of Both Warfarin and NOACs (Clone)

Part 3 in a 5 part series - Improving the Quality of Chronic Oral Anticoagulation with Evidence-Based Guidelines

 

...

Continue Reading

Overview of EHR Key Features Necessary for Delivering Optimized AC Therapy (Clone)

Part 4 in a 5 part series - Improving the Quality of Chronic Oral Anticoagulation with Evidence-Based Guidelines.

 

...

Continue Reading

Northwell Health System's Integration with Point of Care Anticoagulation (AC) Software (Clone)

Part 5 in a 5 part series - Improving the Quality of Chronic Oral Anticoagulation with Evidence-Based Guidelines.

 

...

Continue Reading